文献速递甲状腺与颈部外科围术期管理与 ERAS

肾移植术后甲状旁腺切除术对移植物失败的影响

Second Chances or Setbacks: The Impact of Parathyroidectomy on Graft Failure Post-Kidney Transplantation.
PubMed 文献 · J Am Coll Surg · 2026-04-16

该回顾性队列研究基于多机构数据库,比较肾移植后三发性甲状旁腺功能亢进患者接受西那卡塞或甲状旁腺切除术的结局。倾向评分匹配后每组811例,随访5年,甲状旁腺切除术组透析依赖、肾性骨营养不良和移植物失败率均低于西那卡塞组,但结论需谨慎解读临床相关性。

要点

  • 肾移植后三发性甲旁亢患者中,甲状旁腺切除术较西那卡塞与更低的移植物失败率相关。
  • 甲状旁腺切除术组透析依赖比例(30.9%)低于西那卡塞组(42.8%),差异有统计学意义。
  • 肾性骨营养不良发生率手术组(5.1%)低于药物组(10.8%),但研究为回顾性需谨慎解读。

核心结论

  • 肾移植后三发性甲旁亢患者接受甲状旁腺切除术者移植物失败和透析依赖率低于西那卡塞治疗者。
  • 电解质平衡和甲状旁腺激素水平改善可能与肾性骨营养不良发生率降低相关。

研究设计与样本

  • 回顾性分析多机构数据库(TriNetX)电子病历,纳入肾移植后诊断为三发性甲旁亢的患者。
  • 按干预方式分为西那卡塞组和甲状旁腺切除术组,随访至多5年,从开始治疗或手术次日起算。
  • 采用倾向评分匹配平衡人口学、合并症、干预前肌酐水平和维生素D缺乏,匹配后每组811例。
  • 采用Cox回归分析确定关联指标。

主要发现

  • 西那卡塞组42.8%(347/811)患者转为透析依赖,手术组为30.9%(251/811),p<0.01。
  • 西那卡塞组10.8%(74/684)发生肾性骨营养不良,手术组为5.1%(32/628),p<0.01。
  • 西那卡塞组17.2%发生移植物失败,手术组为12.6%,p<0.04。

临床怎么用

  • 对于肾移植后三发性甲旁亢患者,甲状旁腺切除术可能较西那卡塞降低移植物失败和透析依赖风险。
  • 临床决策时需结合患者个体情况,并注意该回顾性研究结论的临床相关性需谨慎解读。

局限性

  • 研究为回顾性分析,存在固有偏倚,结论应谨慎解读其临床相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tertiary hyperparathyroidism is a common complication in kidney transplant (KT) recipients, often persisting despite successful graft function. However, the optimal treatment for improving long-term graft survival remains unclear. Parathyroidectomy (PTX) offers a definitive approach to restoring calcium homeostasis. This study aims to assess the effect of PTX on graft failure, the need for dialysis, and renal osteodystrophy in the 2 groups. STUDY DESIGN: A retrospective analysis of electronic medical records from a multi-institutional database (TriNetX) was completed. Patients diagnosed with tertiary hyperparathyroidism after KT were divided into 2 groups based on the type of intervention: cinacalcet or PTX. Patients were followed for up to 5 years, starting from the day after initiating cinacalcet or PTX. Propensity score matching was used to balance demographics, comorbidities, creatinine levels before intervention, and vitamin D deficiency. Cox regression analysis was performed to determine measures of association. RESULTS: A total of 811 patients were included in each treatment group after propensity score matching. During the study period, 42.8% of patients (n = 347 of 811) receiving cinacalcet became dialysis-dependent, compared with 30.9% (n = 251 of 811) of those who underwent surgery (p < 0.01). Regarding renal osteodystrophy, 10.8% of patients (n = 74 of 684) on cinacalcet developed the condition, whereas only 5.1% (n = 32 of 628) in the PTX group experienced it (p < 0.01). Additionally, 17.2% of those on cinacalcet experienced graft failure, compared with 12.6% in the PTX group (p < 0.04). CONCLUSIONS: Patients who underwent PTX experienced lower rates of KT failure and dialysis, outperforming those treated with cinacalcet; however, this finding should be cautiously interpreted regarding its clinical relevance. Improved electrolyte balance and parathyroid hormone levels may be associated with a lower rate of renal osteodystrophy.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Kasmirski JA, Swaminathan N, Roy R, et al. Second Chances or Setbacks: The Impact of Parathyroidectomy on Graft Failure Post-Kidney Transplantation. J Am Coll Surg. 2026. PMID: 41315018. doi:10.1097/XCS.0000000000001687

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。